Dr. Arun A. Rangaswami
Claim this profileUCSF Medical Center-Mission Bay
Expert in Cancer
Expert in Neuroblastoma
30 reported clinical trials
86 drugs studied
Area of expertise
1Cancer
Global LeaderStage I
Stage IV
Stage II
2Neuroblastoma
Global LeaderMYC positive
Stage IV
MYC negative
Affiliated Hospitals
Clinical Trials Arun A. Rangaswami is currently running
Health Study After Leukemia Treatment
for People With Down Syndrome
This study attempts to learn more about the health of persons with Down syndrome after treatment for acute leukemia. Children with Down syndrome are at increased risk for side effects during treatment for acute leukemia, but it is unclear of their risk for long-term effects of cancer treatment. By learning more about the factors that may contribute to chronic health conditions and long-term effects after treatment for leukemia in persons with Down syndrome, clinical practice guidelines for survivorship care can be developed to help improve their quality-of-life.
Recruiting1 award N/A10 criteria
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
More about Arun A. Rangaswami
Clinical Trial Related8 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Arun A. Rangaswami has experience with
- Cisplatin
- Cyclophosphamide
- Carboplatin
- Etoposide
- Palbociclib
- Olaparib
Breakdown of trials Arun A. Rangaswami has run
Cancer
Neuroblastoma
Brain Tumor
Rhabdomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Arun A. Rangaswami specialize in?
Arun A. Rangaswami focuses on Cancer and Neuroblastoma. In particular, much of their work with Cancer has involved Stage I patients, or patients who are Stage IV.
Is Arun A. Rangaswami currently recruiting for clinical trials?
Yes, Arun A. Rangaswami is currently recruiting for 10 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Arun A. Rangaswami has studied deeply?
Yes, Arun A. Rangaswami has studied treatments such as Cisplatin, Cyclophosphamide, Carboplatin.
What is the best way to schedule an appointment with Arun A. Rangaswami?
Apply for one of the trials that Arun A. Rangaswami is conducting.
What is the office address of Arun A. Rangaswami?
The office of Arun A. Rangaswami is located at: UCSF Medical Center-Mission Bay, San Francisco, California 94158 United States. This is the address for their practice at the UCSF Medical Center-Mission Bay.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.